10-144-283 Me. Code R. § 8

Current through 2024-51, December 18, 2024

Section 144-283-8 - SCREENING TEST PERFORMED

A. The Department will consider changes in conditions to be screened as requested by the Joint Advisory Committee, the medical community or the public. The Department reviews the recommendations from the Advisory Committee on Heritable Disorders in Newborns and Children and the Recommended Uniform Screening Panel (RUSP), and data from medical experts and other newborn screening programs, when considering a new condition. Rulemaking to add conditions will be conducted in accordance with 5 MRS §§ 8001 - 11008.

B. The Department must determine conditions to be screened, considering whether:

1. The condition has significant mortality and morbidity when not diagnosed before symptoms appear;

2. The condition may not be identified early clinically;

3. The prevalence of the condition in the population is significant;

4. Pre-symptomatic treatment affects outcome;

5. A simple, inexpensive and effective screening method is available; and

6. Resources for treatment and counseling are available.

7. The costs of screening, diagnosis and treatment can be justified by increases in well-being and quality of life for affected individuals and their families.

C. As of the effective date of this rule, all newborn blood specimens must be tested for laboratory markers for the conditions specified in this rule. See Appendix A for a list of specified core conditions and secondary conditions.

10-144 C.M.R. ch. 283, § 8